Connect with us

Science

DeepBAR: AI-Based Technique That May Speed Drug Discovery – Genetic Engineering & Biotechnology News

DeepBAR is a new technique that combines chemistry and machine learning to speed up calculations of drug molecules’ binding affinity to proteins.

Published

on

Article feature image

A new technique, DeepBAR, quickly calculates the binding affinities between drug candidates and their targets. The approach, which combines chemistry and machine learning, could lower a hurdle in the drug discovery process. DeepBAR yields precise calculations in a fraction of the time compared to previous state-of-the-art methods. The inventors say DeepBAR could one day quicken the pace of drug discovery and protein engineering.
“Our method is orders of magnitude faster than before, meaning we can…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending